Literature DB >> 12393262

Correlation of estrogen beta-receptor messenger RNA with endogenous levels of plasma estradiol and progesterone in the female rat hypothalamus, the bed nucleus of stria terminalis and the medial amygdala.

Ceylan Isgor1, Grace C Huang, Huda Akil, Stanley J Watson.   

Abstract

Estrogen receptor beta (ERbeta) has been previously mapped in the rat central nervous system. This study aims to explore the regulation of ERbeta mRNA as it is expressed in the intact and cycling female rat brain. Young adult female rats (90+ day, N=20) were screened for estrous phases via vaginal cytology and sacrificed. Brains and blood were collected and processed for in situ hybridization and estradiol (E2) and progesterone (P4) hormone assays, respectively. ERbeta mRNA levels exhibited significant correlations with ovarian steroid ratios (E2/P4) in various brain regions, including the bed nucleus of stria terminalis, the medial nucleus of amygdala, and the anteroventral periventricular nuclei but not the paraventricular and the supraoptic nuclei or the preoptic area of the hypothalamus. No regulatory changes were detected in the cortex. Specifically, in the affected regions, higher P4 levels were significantly correlated with higher ERbeta mRNA expression. In contrast, there was a tendency for higher E2 levels to be correlated with lower ERbeta mRNA expression, but this tendency reached significance only in the bed nucleus of stria terminalis. These results suggest that ERbeta mRNA is regulated in the intact and cycling female rat hypothalamic as well as extrahypothalamic brain regions, and the circulating ovarian hormones play a critical role.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393262     DOI: 10.1016/s0169-328x(02)00407-2

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  8 in total

1.  Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder.

Authors:  Cynthia Neill Epperson; Brian Pittman; Kathryn Ann Czarkowski; Stephanie Stiklus; John Harrison Krystal; Christian Grillon
Journal:  Neuropsychopharmacology       Date:  2007-02-21       Impact factor: 7.853

2.  Long-term effects of juvenile nicotine exposure on abstinence-related social anxiety-like behavior and amygdalar cannabinoid receptor 1 (CB1R) mRNA expression in the novelty-seeking phenotype.

Authors:  Cigdem Aydin; Ozge Oztan; Ceylan Isgor
Journal:  Behav Brain Res       Date:  2011-11-22       Impact factor: 3.332

3.  Vulnerability to nicotine abstinence-related social anxiety-like behavior: molecular correlates in neuropeptide Y, Y2 receptor and corticotropin releasing factor.

Authors:  Cigdem Aydin; Ozge Oztan; Ceylan Isgor
Journal:  Neurosci Lett       Date:  2010-12-30       Impact factor: 3.046

Review 4.  Effects of hormone replacement therapy on the sympathetic nervous system and blood pressure.

Authors:  J Michael Wyss; Scott H Carlson
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

5.  Effects of prenatal ethanol exposure on hypothalamic-pituitary-adrenal function across the estrous cycle.

Authors:  Ni Lan; Fiona Yamashita; Alison G Halpert; Joanna H Sliwowska; Victor Viau; Joanne Weinberg
Journal:  Alcohol Clin Exp Res       Date:  2009-03-23       Impact factor: 3.455

6.  Electron-microscopic characteristics of neuroendocrine neurons in the amygdaloid body of the brain in male rats and female rats at different stages of the estral cycle.

Authors:  A V Akhmadeev; L B Kalimullina
Journal:  Neurosci Behav Physiol       Date:  2008-01

7.  Estrogen affects levels of Bcl-2 protein and mRNA in medial amygdala of ovariectomized rats.

Authors:  Lu Fan; Subhash C Pandey; Rochelle S Cohen
Journal:  J Neurosci Res       Date:  2008-12       Impact factor: 4.164

8.  Sexually dimorphic enhancement by estradiol of male urinary odor detection thresholds in mice.

Authors:  Krystina G Sorwell; Daniel W Wesson; Michael J Baum
Journal:  Behav Neurosci       Date:  2008-08       Impact factor: 1.912

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.